Search

Your search keyword '"Huang, Guiqing"' showing total 20 results
Start Over Author "Huang, Guiqing" Publication Year Range Last 10 years
20 results on '"Huang, Guiqing"'

2. The Adaptive Alternation of Intestinal Microbiota and Regulation of Host Genes Jointly Promote Pigs to Digest Appropriate High-Fiber Diets.

Author

Zhang, Yunchao, Li, Hui, Li, Bengao, He, Jiayi, Peng, Chen, Xie, Yanshe, Huang, Guiqing, Zhao, Pengju, and Wang, Zhengguang

Subjects
HIGH-fiber diet, GUT microbiome, GENETIC regulation, GENE expression, SWINE, WHEAT bran, WHEAT breeding, DIETARY fiber
Abstract

Simple Summary: Tunchang pigs are known for their good performance on roughage tolerance, which may alleviate the conflict between humans and livestock for grain resources. This study observed that Tunchang pigs can adapt to a high-fiber diet containing 5% crude fiber. The adaptive alterations in intestinal microbiota and the regulation of genes collectively facilitated the digestion of high-fiber diets in the host. These findings provide insight into the roughage tolerance of Tunchang pigs, and contribute to further exploration of host–microbiota interactions. Although studies have revealed the significant impact of dietary fiber on growth performance and nutrient digestibility, the specific characteristics of the intestinal microbiota and gene regulation in pigs capable of digesting high-fiber diets remained unclear. To investigate the traits associated with roughage tolerance in the Chinese indigenous pig breed, we conducted comparative analysis of growth performance, apparent fiber digestibility, intestinal microbiota, SCFA concentrations and intestinal transcriptome in Tunchang pigs, feeding them diets with different wheat bran levels. The results indicated that the growth performance of Tunchang pigs was not significantly impacted, and the apparent total tract digestibility of crude fiber was significantly improved with increasing dietary fiber content. High-fiber diets altered the diversity of intestinal microbiota, and increased the relative abundance of Prevotella, CF231, as well as the concentrations of isobutyrate, valerate and isovalerate. The LDA analysis identified potential microbial biomarkers that could be associated with roughage tolerance, such as Prevotella stercorea, and Eubacterium biforme. In addition, appropriate high-fiber diets containing 4.34% crude fiber upregulated the mRNA expressions of PYY, AQP8, and SLC5A8, while downregulating the mRNA expressions of CKM and CNN1.This indicated that appropriate high-fiber diets may inhibit intestine motility and increase the absorption of water and SCFAs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Red Phosphorus Grafted High‐Index (116) Faceted Anatase TiO2 for Z‐Scheme Photocatalytic Pure Water Splitting.

Author

Zhu, Yukun, Ren, Jun, Huang, Guiqing, Dong, Chung‐Li, Huang, Yu‐Cheng, Lu, Ping, Tang, Hua, Liu, Yiming, Shen, Shaohua, and Yang, Dongjiang

Subjects
CUCURBITURIL, VALENCE bands, CHEMICAL vapor deposition, TITANIUM dioxide, CONDUCTION bands, PHOSPHORUS
Abstract

Red phosphorus (RP) is an emerging visible‐light‐responsive photocatalyst, yet the rapid charge recombination has limited photocatalytic hydrogen production activity. In this work, a Z‐scheme heterostructure with RP nanolayer coated on high‐index (116) faceted anatase TiO2 nanoparticles (TiO2@RP) is designed and fabricated via chemical vapor deposition. Compared with pristine TiO2 and RP, the optimized TiO2@RP Z‐scheme heterostructure exhibits a significantly boosted photocatalytic activity for pure water splitting, with hydrogen evolution rate reaching 12.9 µmol·h−1, under simulated solar light irradiation. The strong interfacial interaction and staggered band alignment between (116) faceted TiO2 and RP result in the formation of built‐in electric field, which can drive the directional charge migration from the conduction band (CB) of TiO2 to the valance band (VB) of RP under light irradiation, with photoelectrons and holes of high redox ability maintained at the CB of RP and the VB of TiO2, respectively. This well‐designed heterostructure greatly promotes photogenerated charge separation and migration via a direct Z‐scheme charge transfer pathway. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Data from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table 3 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Table 4 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Table 2 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table 5 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table 1 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Materials and Methods from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Methods, Figures 1-4, Movie Legend, Table Legends 1-5 from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Movie from The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

Author

Littlepage, Laurie E., primary, Adler, Adam S., primary, Kouros-Mehr, Hosein, primary, Huang, Guiqing, primary, Chou, Jonathan, primary, Krig, Sheryl R., primary, Griffith, Obi L., primary, Korkola, James E., primary, Qu, Kun, primary, Lawson, Devon A., primary, Xue, Qing, primary, Sternlicht, Mark D., primary, Dijkgraaf, Gerrit J.P., primary, Yaswen, Paul, primary, Rugo, Hope S., primary, Sweeney, Colleen A., primary, Collins, Colin C., primary, Gray, Joe W., primary, Chang, Howard Y., primary, and Werb, Zena, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results